Publication | Closed Access

The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention

Cannabis UseQ63r VariantAutoimmune DiseaseMedicineImmunologyGenetic EpidemiologyGastroenterologyPathologyClinical PresentationAutoimmunityCeliac DiseaseCannabinoid Receptor